Le Graverand M-P Hellio, Brandt K, Mazzuca S A, Raunig D, Vignon E
Pfizer Global Research and Development, New London, Connecticut, USA.
Ann Rheum Dis. 2009 Nov;68(11):1734-8. doi: 10.1136/ard.2007.085530. Epub 2008 Dec 5.
Given that obesity is a risk factor for osteoarthritis (OA) of the knee, a study was undertaken to determine whether progressively higher body mass index (BMI) among obese women is associated with progressive increases in joint space narrowing (JSN).
Medial compartment JSN over 12 months in Lyon Schuss radiographs of 60 obese women (BMI 30.0-50.5 kg/m(2)) with radiographic and symptomatic OA was compared with that in 81 non-obese women (BMI <28 kg/m(2)) with normal radiographs and minimal or no symptoms of knee OA.
Among the patients with OA, higher BMI tended to be associated with a higher Kellgren and Lawrence (KL) grade of OA severity. JSN in the non-obese controls was negligible, but in the 30 patients with KL grade 2 and KL grade 3 knees, mean (SD) JSN was 0.12 (0.31) mm and 0.32 (0.50) mm, respectively (p<0.005 and p<0.001). No association was seen between baseline BMI and 12-month JSN in patients with OA; indeed, the regression plot suggested a slight inverse relationship between the two.
In obese patients with OA, progressively higher BMI values were not accompanied by a progressively increasing rate of JSN. Joint loading was not evaluated, but it is possible that marked obesity limited the functional capacity of some subjects with OA, protecting their knees from loading. For investigators considering eligibility criteria for a trial of a structure-modifying OA drug, these data suggest that recruitment of patients with a BMI much higher than 30 kg/m(2) will not enrich the sample of subjects who will have more rapid JSN than those with a BMI of only 30 kg/m(2).
鉴于肥胖是膝关节骨关节炎(OA)的一个风险因素,开展了一项研究以确定肥胖女性中逐渐升高的体重指数(BMI)是否与关节间隙狭窄(JSN)的逐渐增加有关。
将60例患有影像学和症状性OA的肥胖女性(BMI 30.0 - 50.5 kg/m²)的里昂舒斯位X线片上12个月内的内侧间室JSN与81例X线片正常且膝关节OA症状轻微或无症状的非肥胖女性(BMI < 28 kg/m²)的进行比较。
在OA患者中,较高的BMI往往与较高的凯尔格伦和劳伦斯(KL)OA严重程度分级相关。非肥胖对照组的JSN可忽略不计,但在30例KL 2级和KL 3级膝关节患者中,平均(标准差)JSN分别为0.12(0.31)mm和0.32(0.50)mm(p < 0.005和p < 0.001)。OA患者的基线BMI与12个月时的JSN之间未发现关联;实际上,回归图显示两者之间存在轻微的负相关。
在患有OA的肥胖患者中,BMI值逐渐升高并未伴随JSN速率的逐渐增加。未评估关节负荷,但有可能明显肥胖限制了一些OA患者的功能能力,保护了他们的膝关节免受负荷。对于考虑结构改变性OA药物试验入选标准的研究者来说,这些数据表明招募BMI远高于30 kg/m²的患者不会使比BMI仅为30 kg/m²的患者有更快JSN的受试者样本增加。